Q15582 (BGH3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 128.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Transforming growth factor-beta-induced protein ig-h3 Short name=Beta ig-h3 Alternative name(s): Kerato-epithelin RGD-containing collagen-associated protein Short name=RGD-CAP | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 683 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Binds to type I, II, and IV collagens. This adhesion protein may play an important role in cell-collagen interactions. In cartilage, may be involved in endochondral bone formation. |
| Subcellular location | Secreted › extracellular space › extracellular matrix. Note: May be associated both with microfibrils and with the cell surface. |
| Tissue specificity | Highly expressed in the corneal epithelium. Ref.8 |
| Induction | By TGFB1. |
| Post-translational modification | Gamma-carboxyglutamate residues are formed by vitamin K dependent carboxylation. These residues are essential for the binding of calcium By similarity. |
| Involvement in disease | Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD) [MIM:121820]; also known as Cogan corneal dystrophy or map-dot-fingerprint type corneal dystrophy. EBMD is a bilateral anterior corneal dystrophy characterized by grayish epithelial fingerprint lines, geographic map-like lines, and dots (or microcysts) on slit-lamp examination. Pathologic studies show abnormal, redundant basement membrane and intraepithelial lacunae filled with cellular debris. Although this disorder usually is not considered to be inherited, families with autosomal dominant inheritance have been identified. Ref.30 Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1) [MIM:121900]; also known as corneal dystrophy granular type. Inheritance is autosomal dominant. Corneal dystrophies show progressive opacification of the cornea leading to severe visual handicap. Ref.27 Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1) [MIM:122200]. Inheritance is autosomal dominant. Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB) [MIM:602082]; also known as corneal dystrophy of Bowman layer type 2 (CDB2). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB) [MIM:608470]; also known as corneal dystrophy of Bowman layer type 1 (CDB1). Ref.13 Ref.15 Ref.27 Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A) [MIM:608471]. CDL3A clinically resembles to lattice corneal dystrophy type 3, but differs in that its age of onset is 70 to 90 years. It has an autosomal dominant inheritance pattern. Ref.12 Ref.28 Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD) [MIM:607541]. ACD could be considered a variant of granular dystrophy with a significant amyloidogenic tendency. Inheritance is autosomal dominant. |
| Sequence similarities | Contains 1 EMI domain. Contains 4 FAS1 domains. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell adhesion Sensory transduction Vision |
| Cellular component | Amyloid Extracellular matrix Secreted |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation |
| Domain | Repeat Signal |
| PTM | Disulfide bond Gamma-carboxyglutamic acid |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | angiogenesis Inferred from expression pattern. Source: UniProtKB cell adhesionInferred from electronic annotation. Source: UniProtKB-KW cell proliferationTraceable author statement. Source: ProtInc negative regulation of cell adhesionTraceable author statement. Source: ProtInc response to stimulusInferred from electronic annotation. Source: UniProtKB-KW visual perceptionTraceable author statement. Source: ProtInc |
| Cellular component | extracellular space Traceable author statement. Source: ProtInc plasma membraneTraceable author statement. Source: Reactome |
| Molecular function | integrin binding Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 23 | 23 | By similarity | |||||||||||||||||||||||||||||||||
| Chain | 24 – 683 | 660 | Transforming growth factor-beta-induced protein ig-h3 | PRO_0000008769 | ||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||
| Domain | 45 – 99 | 55 | EMI | |||||||||||||||||||||||||||||||||
| Domain | 103 – 236 | 134 | FAS1 1 | |||||||||||||||||||||||||||||||||
| Domain | 240 – 371 | 132 | FAS1 2 | |||||||||||||||||||||||||||||||||
| Domain | 375 – 498 | 124 | FAS1 3 | |||||||||||||||||||||||||||||||||
| Domain | 502 – 632 | 131 | FAS1 4 | |||||||||||||||||||||||||||||||||
| Motif | 642 – 644 | 3 | Cell attachment site Potential | |||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||
| Modified residue | 108 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 126 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 131 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 133 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 146 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 154 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 166 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 184 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 248 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 250 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 254 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 270 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 283 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 286 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 291 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 301 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 319 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 328 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 331 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 336 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 529 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 534 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 545 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 554 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 564 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 576 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 598 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 611 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Modified residue | 615 | 1 | 4-carboxyglutamate Potential | |||||||||||||||||||||||||||||||||
| Disulfide bond | 49 ↔ 85 | By similarity | ||||||||||||||||||||||||||||||||||
| Disulfide bond | 65 ↔ 74 | By similarity | ||||||||||||||||||||||||||||||||||
| Disulfide bond | 84 ↔ 97 | By similarity | ||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||
| Natural variant | 113 | 1 | V → I in granular corneal dystrophy; unclassified form; with centrifuge pattern of opacities. Ref.33 | VAR_031531 | ||||||||||||||||||||||||||||||||
| Natural variant | 123 | 1 | D → H in granular corneal dystrophy; unclassified form; Hanoi. Ref.25 | VAR_031532 | ||||||||||||||||||||||||||||||||
| Natural variant | 124 | 1 | R → C in CDL1. Ref.2 Ref.11 Ref.18 Ref.22 Ref.23 Ref.27 | VAR_005076 | ||||||||||||||||||||||||||||||||
| Natural variant | 124 | 1 | R → H in ACD; most common mutation in Japanese. Ref.2 Ref.11 Ref.16 Ref.18 Ref.22 Ref.23 | VAR_005077 | ||||||||||||||||||||||||||||||||
| Natural variant | 124 | 1 | R → L in CDRB. Ref.13 Ref.18 Ref.19 Ref.22 Ref.27 | VAR_005078 | ||||||||||||||||||||||||||||||||
| Natural variant | 124 | 1 | R → S in CDGG1; late-onset; mild ocular irritation and reduction in visual acuity. Ref.16 Ref.23 | VAR_012444 | ||||||||||||||||||||||||||||||||
| Natural variant | 125 – 126 | 2 | Missing Associated with Leu-124 in atypical granular dystrophy; French granular variant. | VAR_012445 | ||||||||||||||||||||||||||||||||
| Natural variant | 200 | 1 | I → F. Ref.3 Corresponds to variant rs45455404 [ dbSNP | Ensembl ]. | VAR_014335 | ||||||||||||||||||||||||||||||||
| Natural variant | 269 | 1 | L → F. Ref.27 | VAR_031533 | ||||||||||||||||||||||||||||||||
| Natural variant | 496 | 1 | R → G. Corresponds to variant rs10057190 [ dbSNP | Ensembl ]. | VAR_031534 | ||||||||||||||||||||||||||||||||
| Natural variant | 501 | 1 | P → T in CDL3A. Ref.12 Ref.18 | VAR_005079 | ||||||||||||||||||||||||||||||||
| Natural variant | 505 | 1 | V → D in CDL1. Ref.29 | VAR_031535 | ||||||||||||||||||||||||||||||||
| Natural variant | 509 | 1 | L → R in EBMD. Ref.30 | VAR_031536 | ||||||||||||||||||||||||||||||||
| Natural variant | 518 | 1 | L → P in CDL1. Ref.20 | VAR_012446 | ||||||||||||||||||||||||||||||||
| Natural variant | 518 | 1 | L → R in CDL1; severe phenotype; delayed age of onset. Ref.23 | VAR_018484 | ||||||||||||||||||||||||||||||||
| Natural variant | 527 | 1 | L → R in CDL1; late-onset; found also in sporadic cases. Ref.14 Ref.18 Ref.21 | VAR_005080 | ||||||||||||||||||||||||||||||||
| Natural variant | 538 | 1 | T → R in CDL1; delayed age of onset. Ref.23 | VAR_018485 | ||||||||||||||||||||||||||||||||
| Natural variant | 539 | 1 | V → D in lattice corneal dystrophy; unclassified form. Ref.27 | VAR_031537 | ||||||||||||||||||||||||||||||||
| Natural variant | 540 | 1 | F → S in CDL3A. Ref.28 | VAR_031538 | ||||||||||||||||||||||||||||||||
| Natural variant | 540 | 1 | Missing in CDRB. | VAR_005081 | ||||||||||||||||||||||||||||||||
| Natural variant | 544 | 1 | N → S in CDL; late-onset. Ref.18 | VAR_012447 | ||||||||||||||||||||||||||||||||
| Natural variant | 546 | 1 | A → D in CDL1; associated with Q-551. Ref.26 | VAR_031539 | ||||||||||||||||||||||||||||||||
| Natural variant | 546 | 1 | A → T in CDL3A. Ref.22 | VAR_012448 | ||||||||||||||||||||||||||||||||
| Natural variant | 551 | 1 | P → Q in CDL1; associated with D-546. Ref.26 | VAR_031540 | ||||||||||||||||||||||||||||||||
| Natural variant | 555 | 1 | R → Q in CDTB; originally thought to cause CDRB. Ref.2 Ref.11 Ref.18 Ref.22 | VAR_005082 | ||||||||||||||||||||||||||||||||
| Natural variant | 555 | 1 | R → W in CDGG1; common mutation in Europe and United States; rare in Japan. Ref.2 Ref.11 Ref.16 Ref.18 Ref.22 Ref.23 Ref.27 | VAR_005083 | ||||||||||||||||||||||||||||||||
| Natural variant | 569 | 1 | L → R in CDL1. Ref.24 | VAR_031541 | ||||||||||||||||||||||||||||||||
| Natural variant | 572 | 1 | H → R in CDL1; late-onset. Ref.31 | VAR_031543 | ||||||||||||||||||||||||||||||||
| Natural variant | 572 | 1 | Missing in CDL1; late-onset and unilateral phenotype. | VAR_031542 | ||||||||||||||||||||||||||||||||
| Natural variant | 594 | 1 | G → V in lattice corneal dystrophy; unclassified form. Ref.27 | VAR_031544 | ||||||||||||||||||||||||||||||||
| Natural variant | 622 | 1 | N → H in asymmetric lattice corneal dystrophy. Ref.17 | VAR_012449 | ||||||||||||||||||||||||||||||||
| Natural variant | 622 | 1 | N → K in CDL3A. Ref.23 | VAR_018486 | ||||||||||||||||||||||||||||||||
| Natural variant | 623 | 1 | G → D in CDL1; delayed age of onset. Ref.23 | VAR_018487 | ||||||||||||||||||||||||||||||||
| Natural variant | 624 – 625 | 2 | Missing in lattice corneal dystrophy; unclassified form. | VAR_031545 | ||||||||||||||||||||||||||||||||
| Natural variant | 626 | 1 | H → P in CDL1. Ref.23 | VAR_018488 | ||||||||||||||||||||||||||||||||
| Natural variant | 626 | 1 | H → R in CDL1; delayed age of onset. Ref.17 Ref.22 Ref.23 Ref.27 | VAR_012450 | ||||||||||||||||||||||||||||||||
| Natural variant | 631 | 1 | V → D in CDL. Ref.23 | VAR_018489 | ||||||||||||||||||||||||||||||||
| Natural variant | 666 | 1 | R → S in EBMD; low penetrance in one family. Ref.30 | VAR_031546 | ||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||
| Helix | 505 – 511 | 7 | ||||||||||||||||||||||||||||||||||
| Helix | 516 – 525 | 10 | ||||||||||||||||||||||||||||||||||
| Helix | 528 – 532 | 5 | ||||||||||||||||||||||||||||||||||
| Beta strand | 533 – 535 | 3 | ||||||||||||||||||||||||||||||||||
| Helix | 545 – 549 | 5 | ||||||||||||||||||||||||||||||||||
| Turn | 552 – 554 | 3 | ||||||||||||||||||||||||||||||||||
| Helix | 555 – 560 | 6 | ||||||||||||||||||||||||||||||||||
| Helix | 562 – 572 | 11 | ||||||||||||||||||||||||||||||||||
| Beta strand | 573 – 576 | 4 | ||||||||||||||||||||||||||||||||||
| Beta strand | 587 – 589 | 3 | ||||||||||||||||||||||||||||||||||
| Beta strand | 591 – 595 | 5 | ||||||||||||||||||||||||||||||||||
| Beta strand | 597 – 602 | 6 | ||||||||||||||||||||||||||||||||||
| Beta strand | 605 – 610 | 6 | ||||||||||||||||||||||||||||||||||
| Beta strand | 612 – 619 | 8 | ||||||||||||||||||||||||||||||||||
| Beta strand | 621 – 630 | 10 | ||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta." Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., Purchio A.F. DNA Cell Biol. 11:511-522(1992) [PubMed: 1388724] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Kerato-epithelin mutations in four 5q31-linked corneal dystrophies." Munier F.L., Korvatska E., Djemai A., le Paslier D., Zografos L., Pescia G., Schorderet D.F. Nat. Genet. 15:247-251(1997) [PubMed: 9054935] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; GLN-555 AND TRP-555. |
| [3] | NIEHS SNPs program Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT PHE-200. |
| [4] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed: 15372022] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [8] | "cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium." Escribano J., Hernando N., Ghosh S., Crabb J., Coca-Prados M. J. Cell. Physiol. 160:511-521(1994) [PubMed: 8077289] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [9] | "Corneal dystrophies in Japan." Fujiki K., Nakayasu K., Kanai A. J. Hum. Genet. 46:431-435(2001) [PubMed: 11501939] [Abstract] Cited for: REVIEW ON VARIANTS CORNEAL DYSTROPHIES. |
| [10] | "Solution structure of the FAS1 domain of human transforming growth factor-beta induced protein IG-H3." RIKEN structural genomics initiative (RSGI) Submitted (JAN-2006) to the PDB data bank Cited for: STRUCTURE BY NMR OF 502-634. |
| [11] | "Mutation hot spots in 5q31-linked corneal dystrophies." Korvatska E., Munier F.L., Djemai A., Wang M.X., Frueh B., Chiou A.G.-Y., Uffer S., Ballestrazzi E., Braunstein R.E., Forster R.K., Culbertson W.W., Boman H., Zografos L., Schorderet D.F. Am. J. Hum. Genet. 62:320-324(1998) [PubMed: 9463327] [Abstract] Cited for: VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; GLN-555 AND TRP-555. |
| [12] | "A kerato-epithelin (beta-ig-h3) mutation in lattice corneal dystrophy type IIIA." Yamamoto S., Okada M., Tsujikawa M., Shimomura Y., Nishida K., Inoue Y., Watanabe H., Maeda N., Kurahashi H., Kinoshita S., Nakamura Y., Tano Y. Am. J. Hum. Genet. 62:719-722(1998) [PubMed: 9497262] [Abstract] Cited for: VARIANT CDL3A THR-501. |
| [13] | "Two distinct kerato-epithelin mutations in Reis-Bucklers corneal dystrophy." Okada M., Yamamoto S., Tsujikawa M., Watanabe H., Inoue Y., Maeda N., Shimomura Y., Nishida K., Quantock A.J., Kinoshita S., Tano Y. Am. J. Ophthalmol. 126:535-542(1998) [PubMed: 9780098] [Abstract] Cited for: VARIANT CDRB LEU-124. |
| [14] | "A new L527R mutation of the betaIGH3 gene in patients with lattice corneal dystrophy with deep stromal opacities." Fujiki K., Hotta Y., Nakayasu K., Yokoyama T., Takano T., Yamaguchi T., Kanai A. Hum. Genet. 103:286-289(1998) [PubMed: 9799082] [Abstract] Cited for: VARIANT CDL1 ARG-527. |
| [15] | "A common beta ig-h3 gene mutation (delta F540) in a large cohort of Sardinian Reis Buecklers' corneal dystrophy patients." Rozzo C., Fossarello M., Galleri G., Sole G., Serru A., Orzalesi N., Serra A., Pirastu M. Hum. Mutat. 12:215-216(1998) [PubMed: 10660331] [Abstract] Cited for: VARIANT CDRB PHE-540 DEL. |
| [16] | "Heterogeneity in granular corneal dystrophy: identification of three causative mutations in the TGFBI (BIGH3) gene-lessons for corneal amyloidogenesis." Stewart H.S., Ridgway A.E., Dixon M.J., Bonshek R.E., Parveen R., Black G.C. Hum. Mutat. 14:126-132(1999) [PubMed: 10425035] [Abstract] Cited for: VARIANTS CORNEAL DYSTROPHIES HIS-124; SER-124 AND TRP-555. |
| [17] | "A mutation within exon 14 of the TGFBI (BIGH3) gene on chromosome 5q31 causes an asymmetric, late-onset form of lattice corneal dystrophy." Stewart H.S., Black G.C., Donnai D., Bonshek R.E., McCarthy J., Morgan S., Dixon M.J., Ridgway A.A. Ophthalmology 106:964-970(1999) [PubMed: 10328397] [Abstract] Cited for: VARIANTS CDL HIS-622 AND ARG-626. |
| [18] | "Association of autosomal dominantly inherited corneal dystrophies with BIGH3 gene mutations in Japan." Mashima Y., Yamamoto S., Inoue Y., Yamada M., Konishi M., Watanabe H., Maeda N., Shimomura Y., Kinoshita S. Am. J. Ophthalmol. 130:516-517(2000) [PubMed: 11024425] [Abstract] Cited for: VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; LEU-124; THR-501; ARG-527; SER-544; GLN-555 AND TRP-555. |
| [19] | "A novel variant of granular corneal dystrophy caused by association of 2 mutations in the TGFBI gene-R124L and deltaT125-deltaE126." Dighiero P., Drunat S., D'Hermies F., Renard G., Delpech M., Valleix S. Arch. Ophthalmol. 118:814-818(2000) [PubMed: 10865320] [Abstract] Cited for: VARIANTS CORNEAL DYSTROPHIES LEU-124 AND 125-THR-GLU-126 DEL. |
| [20] | "Corneal amyloidosis caused by Leu518Pro mutation of betaig-h3 gene." Hirano K., Hotta Y., Fujiki K., Kanai A. Br. J. Ophthalmol. 84:583-585(2000) [PubMed: 10837380] [Abstract] Cited for: VARIANT CDL1 PRO-518. |
| [21] | "Late-onset form of lattice corneal dystrophy caused by Leu527Arg mutation of the TGFBI gene." Hirano K., Hotta Y., Nakamura M., Fujiki K., Kanai A., Yamamoto N. Cornea 20:525-529(2001) [PubMed: 11413411] [Abstract] Cited for: VARIANT CDL1 ARG-527. |
| [22] | "Histologic phenotype-genotype correlation of corneal dystrophies associated with eight distinct mutations in the TGFBI gene." Dighiero P., Niel F., Ellies P., D'Hermies F., Savoldelli M., Renard G., Delpech M., Valleix S. Ophthalmology 108:818-823(2001) [PubMed: 11297504] [Abstract] Cited for: VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; LEU-124; 125-THR-GLU-126 DEL; THR-546; GLN-555; TRP-555 AND ARG-626. |
| [23] | "BIGH3 mutation spectrum in corneal dystrophies." Munier F.L., Frueh B.E., Othenin-Girard P., Uffer S., Cousin P., Wang M.X., Heon E., Black G.C.M., Blasi M.A., Balestrazzi E., Lorenz B., Escoto R., Barraquer R., Hoeltzenbein M., Gloor B., Fossarello M., Singh A.D., Arsenijevic Y., Zografos L., Schorderet D.F. Invest. Ophthalmol. Vis. Sci. 43:949-954(2002) [PubMed: 11923233] [Abstract] Cited for: VARIANTS CORNEAL DYSTROPHIES CYS-124; HIS-124; SER-124; ARG-518; ARG-538; PHE-540 DEL; TRP-555; LYS-622; ASP-623; ARG-626; PRO-626 AND ASP-631. |
| [24] | "A new mutation (Leu569Arg) within exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I." Warren J.F., Abbott R.L., Yoon M.K., Crawford J.B., Spencer W.H., Margolis T.P. Am. J. Ophthalmol. 136:872-878(2003) [PubMed: 14597039] [Abstract] Cited for: VARIANT CDL1 ARG-569. |
| [25] | "A novel mutation of the TGFBI gene found in a Vietnamese family with atypical granular corneal dystrophy." Ha N.T., Cung le X., Chau H.M., Thanh T.K., Fujiki K., Murakami A., Kanai A. Jpn. J. Ophthalmol. 47:246-248(2003) [PubMed: 12782158] [Abstract] Cited for: VARIANT GRANULAR CORNEAL DYSTROPHY HIS-123. |
| [26] | "Lattice corneal dystrophy associated with the Ala546Asp and Pro551Gln missense changes in the TGFBI gene." Aldave A.J., Gutmark J.G., Yellore V.S., Affeldt J.A., Meallet M.A., Udar N., Rao N.A., Small K.W., Klintworth G.K. Am. J. Ophthalmol. 138:772-781(2004) [PubMed: 15531312] [Abstract] Cited for: VARIANTS CDL1 ASP-546 AND GLN-551. |
| [27] | "TGFBI gene mutations causing lattice and granular corneal dystrophies in Indian patients." Chakravarthi S.V.V.K., Kannabiran C., Sridhar M.S., Vemuganti G.K. Invest. Ophthalmol. Vis. Sci. 46:121-125(2005) [PubMed: 15623763] [Abstract] Cited for: VARIANTS CDL1 CYS-124 AND ARG-626, VARIANT CDRB LEU-124, VARIANT CDGG1 TRP-555, VARIANTS LATTICE CORNEAL DYSTROPHY ASP-539; VAL-594 AND 624-VAL-VAL-625 DEL, VARIANT PHE-269. |
| [28] | "Hereditary lattice corneal dystrophy is associated with corneal amyloid deposits enclosing C-terminal fragments of keratoepithelin." Stix B., Leber M., Bingemer P., Gross C., Rueschoff J., Faendrich M., Schorderet D.F., Vorwerk C.K., Zacharias M., Roessner A., Roecken C. Invest. Ophthalmol. Vis. Sci. 46:1133-1139(2005) [PubMed: 15790870] [Abstract] Cited for: VARIANT CDL3A SER-540. |
| [29] | "Novel mutation (V505D) of the TGFBI gene found in a Chinese family with lattice corneal dystrophy, type I." Tian X., Fujiki K., Wang W., Murakami A., Xie P., Kanai A., Liu Z. Jpn. J. Ophthalmol. 49:84-88(2005) [PubMed: 15838722] [Abstract] Cited for: VARIANT CDL1 ASP-505. |
| [30] | "A subset of patients with epithelial basement membrane corneal dystrophy have mutations in TGFBI/BIGH3." Boutboul S., Black G.C.M., Moore J.E., Sinton J., Menasche M., Munier F.L., Laroche L., Abitbol M., Schorderet D.F. Hum. Mutat. 27:553-557(2006) [PubMed: 16652336] [Abstract] Cited for: VARIANTS EBMD ARG-509 AND SER-666. |
| [31] | "A novel H572R mutation in the transforming growth factor-beta-induced gene in a Thai family with lattice corneal dystrophy type I." Atchaneeyasakul L.-O., Appukuttan B., Pingsuthiwong S., Yenchitsomanus P.-T., Trinavarat A., Srisawat C. Jpn. J. Ophthalmol. 50:403-408(2006) [PubMed: 17013691] [Abstract] Cited for: VARIANT CDL1 ARG-572. |
| [32] | "Unilateral lattice corneal dystrophy associated with the novel His572del mutation in the TGFBI gene." Aldave A.J., Rayner S.A., Kim B.T., Prechanond A., Yellore V.S. Mol. Vis. 12:142-146(2006) [PubMed: 16541014] [Abstract] Cited for: VARIANT CDL1 HIS-572 DEL. |
| [33] | "Expanding the mutational spectrum in TGFBI-linked corneal dystrophies: identification of a novel and unusual mutation (Val113Ile) in a family with granular dystrophy." Zenteno J.C., Ramirez-Miranda A., Santacruz-Valdes C., Suarez-Sanchez R. Mol. Vis. 12:331-335(2006) [PubMed: 16636649] [Abstract] Cited for: VARIANT GRANULAR CORNEAL DYSTROPHY ILE-113. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M77349 mRNA. Translation: AAA61163.1. AF035626 Genomic DNA. Translation: AAB88695.1. AF035627 Genomic DNA. Translation: AAB88698.1. AF035628 Genomic DNA. Translation: AAB88696.1. AF035629 Genomic DNA. Translation: AAB88697.1. AY149344 Genomic DNA. Translation: AAN10294.1. BT009820 mRNA. Translation: AAP88822.1. AC004503 Genomic DNA. Translation: AAC08449.1. AC005219 Genomic DNA. Translation: AAC24944.1. CH471062 Genomic DNA. Translation: EAW62199.1. CH471062 Genomic DNA. Translation: EAW62200.1. BC000097 mRNA. Translation: AAH00097.1. BC004972 mRNA. Translation: AAH04972.1. | ||||||||||||||||||
| IPI | IPI00018219. | ||||||||||||||||||
| PIR | I52996. | ||||||||||||||||||
| RefSeq | NP_000349.1. NM_000358.2. | ||||||||||||||||||
| UniGene | Hs.369397. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q15582. | ||||||||||||||||||
| SMR | Q15582. Positions 102-239, 242-634. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| STRING | Q15582. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 2498193. | ||||||||||||||||||
2D gel databases | |||||||||||||||||||
| Cornea-2DPAGE | Q15582. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PeptideAtlas | Q15582. | ||||||||||||||||||
| PRIDE | Q15582. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000442011; ENSP00000416330; ENSG00000120708. | ||||||||||||||||||
| GeneID | 7045. | ||||||||||||||||||
| KEGG | hsa:7045. | ||||||||||||||||||
| UCSC | uc003lbf.2. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 7045. | ||||||||||||||||||
| GeneCards | GC05P135392. | ||||||||||||||||||
| H-InvDB | HIX0005197. | ||||||||||||||||||
| HGNC | HGNC:11771. TGFBI. | ||||||||||||||||||
| HPA | HPA008612. | ||||||||||||||||||
| MIM | 121820. phenotype. 121900. phenotype. 122200. phenotype. 601692. gene. 602082. phenotype. 607541. phenotype. 608470. phenotype. 608471. phenotype. | ||||||||||||||||||
| neXtProt | NX_Q15582. | ||||||||||||||||||
| Orphanet | 98963. Corneal dystrophy, Avellino type. 98960. Corneal dystrophy, Thiel-Behnke type. 98956. Microcystic corneal dystrophy. | ||||||||||||||||||
| PharmGKB | PA36484. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | prNOG04611. | ||||||||||||||||||
| HOVERGEN | HBG000715. | ||||||||||||||||||
| InParanoid | Q15582. | ||||||||||||||||||
| OMA | TVISYEC. | ||||||||||||||||||
| OrthoDB | EOG4SN1N8. | ||||||||||||||||||
| PhylomeDB | Q15582. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| Reactome | REACT_75925. Amyloids. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q15582. | ||||||||||||||||||
| Bgee | Q15582. | ||||||||||||||||||
| CleanEx | HS_TGFBI. | ||||||||||||||||||
| Genevestigator | Q15582. | ||||||||||||||||||
| GermOnline | ENSG00000120708. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR011489. EMI_domain. IPR000782. FAS1_domain. IPR016666. TGFb-ind_bIGH3/osteoblast_fac2. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:2.30.180.10. BIgH3_FAS1. 4 hits. | ||||||||||||||||||
| Pfam | PF02469. Fasciclin. 4 hits. [Graphical view] | ||||||||||||||||||
| PIRSF | PIRSF016553. BIGH3_OSF2. 1 hit. | ||||||||||||||||||
| SMART | SM00554. FAS1. 4 hits. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF82153. BIgH3_FAS1. 4 hits. | ||||||||||||||||||
| PROSITE | PS51041. EMI. 1 hit. PS50213. FAS1. 4 hits. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| NextBio | 27529. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | BGH3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q15582 Secondary accession number(s): D3DQB1 Q53XM1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with